In a suit filed against CVS, Walgreens, GE Healthcare and many other medical technology companies and sellers of pulse oximeters – devices that use light to measure oxygen saturation in the blood – Medtronic has been dismissed, the company said in a statement Monday.
Meanwhile, the U.S. Food and Drug Administration has been working to update its 2013 guidance on pulse oximetry submissions; publication and public comment have been pushed…